Sarepta Therapeutics Stock Technical Analysis
SRPT Stock | USD 116.55 1.34 1.14% |
As of the 19th of April, Sarepta Therapeutics has the Coefficient Of Variation of 5727.81, risk adjusted performance of 0.0178, and Semi Deviation of 1.97. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sarepta Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Sarepta Therapeutics, which can be compared to its competition. Please validate Sarepta Therapeutics information ratio and downside variance to decide if Sarepta Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 116.55 per share. Given that Sarepta Therapeutics has jensen alpha of (0.01), we advise you to double-check Sarepta Therapeutics's current market performance to make sure the company can sustain itself at a future point.
Sarepta Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sarepta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SareptaSarepta |
Sarepta Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
180.61 | Strong Buy | 22 | Odds |
Most Sarepta analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sarepta stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sarepta Therapeutics, talking to its executives and customers, or listening to Sarepta conference calls.
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sarepta Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sarepta Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sarepta Therapeutics Trend Analysis
Use this graph to draw trend lines for Sarepta Therapeutics. You can use it to identify possible trend reversals for Sarepta Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sarepta Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sarepta Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sarepta Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Sarepta Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 7.08, which is the sum of squared deviations for the predicted Sarepta Therapeutics price change compared to its average price change.About Sarepta Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sarepta Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sarepta Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sarepta Therapeutics price pattern first instead of the macroeconomic environment surrounding Sarepta Therapeutics. By analyzing Sarepta Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sarepta Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sarepta Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 89.26 | 101.59 | 129.08 | 211.11 | PTB Ratio | 7.89 | 29.47 | 10.37 | 6.7 |
Sarepta Therapeutics April 19, 2024 Technical Indicators
Most technical analysis of Sarepta help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sarepta from various momentum indicators to cycle indicators. When you analyze Sarepta charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0178 | |||
Market Risk Adjusted Performance | 0.0563 | |||
Mean Deviation | 1.38 | |||
Semi Deviation | 1.97 | |||
Downside Deviation | 2.01 | |||
Coefficient Of Variation | 5727.81 | |||
Standard Deviation | 2.05 | |||
Variance | 4.21 | |||
Information Ratio | (0.02) | |||
Jensen Alpha | (0.01) | |||
Total Risk Alpha | (0.17) | |||
Sortino Ratio | (0.02) | |||
Treynor Ratio | 0.0463 | |||
Maximum Drawdown | 14.76 | |||
Value At Risk | (2.85) | |||
Potential Upside | 3.23 | |||
Downside Variance | 4.03 | |||
Semi Variance | 3.86 | |||
Expected Short fall | (1.42) | |||
Skewness | 0.3099 | |||
Kurtosis | 4.07 |
Sarepta Therapeutics April 19, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sarepta stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 13,041 | ||
Daily Balance Of Power | (0.43) | ||
Rate Of Daily Change | 0.99 | ||
Day Median Price | 117.35 | ||
Day Typical Price | 117.08 | ||
Price Action Indicator | (1.47) |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sarepta Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Sarepta Stock please use our How to Invest in Sarepta Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Sarepta Stock analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Sarepta Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sarepta Therapeutics. If investors know Sarepta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sarepta Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.80) | Revenue Per Share 13.456 | Quarterly Revenue Growth 0.535 | Return On Assets (0.05) | Return On Equity (0.86) |
The market value of Sarepta Therapeutics is measured differently than its book value, which is the value of Sarepta that is recorded on the company's balance sheet. Investors also form their own opinion of Sarepta Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sarepta Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sarepta Therapeutics' market value can be influenced by many factors that don't directly affect Sarepta Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sarepta Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sarepta Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sarepta Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.